Efficacy of Continuous Versus Intermittent Administration of Penicillin G in Streptococcus Pneumoniae Pneumonia in Normal and Immunodeficient Rats
Overview
Authors
Affiliations
An experimental Streptococcus pneumoniae pneumonia was used to study the influence of continuous versus intermittent administration of penicillin G on therapeutic efficacy in normal rats and in rats whose phagocytic capacities were impaired by decomplementation with cobra venom factor. Response to antibiotic treatment was evaluated with respect to numbers of bacteria in left lung, blood and pleural fluid. Penicillin treatment was started 36 h after bacterial inoculation, and continued for four days. With intermittent intramuscular administration of penicillin normal rats were cured after daily doses of 4 mg/kg at 12 h intervals, whereas decomplemented rats recovered only after daily doses of 100 or 102 mg/kg at 12 h or 8 h intervals, respectively. When penicillin was administered by way of continuous infusion, daily doses of 3.5 mg/kg were required for a cure of infections in both normal rats and in decomplemented rats. This treatment resulted in a constant level of 0.05 micrograms of penicillin per ml, which was slightly above the minimum bactericidal concentration for the infecting strain. These findings show that maintenance of bactericidal levels of penicillin were particularly important in curing severe infection in rats with impaired defense.
Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.
Grupper M, Kuti J, Nicolau D Clin Microbiol Rev. 2016; 29(4):759-72.
PMID: 27413094 PMC: 5010748. DOI: 10.1128/CMR.00022-16.
Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.
Goulenok T, Fantin B Clin Pharmacokinet. 2013; 52(10):869-83.
PMID: 23807657 DOI: 10.1007/s40262-013-0086-1.
Bakker-Woudenberg I, Ten Kate M, Goessens W, Mouton J Antimicrob Agents Chemother. 2006; 50(9):2919-25.
PMID: 16940082 PMC: 1563558. DOI: 10.1128/AAC.00859-05.
Lau W, Mercer D, Itani K, Nicolau D, Kuti J, Mansfield D Antimicrob Agents Chemother. 2006; 50(11):3556-61.
PMID: 16940077 PMC: 1635208. DOI: 10.1128/AAC.00329-06.
Berkhout J, Visser L, van den Broek P, van de Klundert J, Mattie H Antimicrob Agents Chemother. 2003; 47(6):1862-6.
PMID: 12760859 PMC: 155817. DOI: 10.1128/AAC.47.6.1862-1866.2003.